Blog Highlights
- Enterprise Systems Embedding AI AI refers to the deployment of technologies such as machine learning, agentic AI, predictive analytics, and generative AI directly into essential business processes.
- Organizations which embed an AI function within their operational systems can achieve faster decisions, superior forecasts, and a positive financial impact.
- The advent of Agentic AI The role of agentic AI As an automation technology that can execute workflows, handle governance decisions, perform compliance checks, and manage escalations- agentic AI has been rapidly establishing itself as a major capability for enterprise organizations.
- By offering enhanced forecasting of resources, clearer sight of project finances, better project delivery risk foresight, better portfolio controls IT, pharma, EPC and GCC entities all see increased business benefit with AI.
- Kytes powers AI-native enterprise delivery with live data intelligence, proactive financial planning, automated compliance and industry-focused AI models.
A pharma project management software is specially designed for overseeing a drug from its initial stage – molecule selection, right through to filing and regulatory submission. It acts as an all-inclusive pharma workflow solution for managing stages, clinical trail timelines, budget, drug file (dossier) development, human resources and regulatory filing/compliance. Generalist project management software can’t accommodate the stringent requirements within the pharmaceutical sector. When you invest in the correct pharma management software for 2026, that can be a ten-year to seven-year difference for your new drug going to market.
What Is a Pharma Project Management System?
A pharma project management system is a dedicated software system used to oversee the complexity of developing products in the pharmaceutical industry, encompassing from drug discovery (molecule identification and business case) up through pre-clinical studies, clinical studies, regulatory filing and commercial launch.

This lifecycle cannot be managed with a “one-size-fits-all” project management tool. The cycles are longer, there is much more to manage around regulations, and the data amount – be it around clinical trial documentation or regulatory filings – is totally incomparable to any other industry. Therefore, a pharma project management system is a tool which will typically offer built in workflows, R&D budgets management, automated governance processes, automated processes around Drug File Tracking (with versioning capability) and the ability to automate regulatory milestone tracking – from FDA, through to EMA or even the CDSCO.
Why Generic Project Management Tools Fail in Pharma
Point solution projects management software and disparate manual processes will never be able to cope with the pace and needs of the current state of drug development. You know the failure mode. Implement generic tool; get started; then, when you move to the clinical trial phase, your world gets complex quickly. The dossier expands, you have to check the R&D budget on a weekly basis and your team starts managing two systems – the platform and the spread sheets. This double-tracking issue now builds version risk directly into your submissions to the FDA and other regulatory agencies.

Three specific failures characterize every generic tool deployment in pharma:

The Four Phases Where a Pharma Project Management System Delivers Most Value

How Kytes Delivers the Pharma Project Management System for NPD
Kytes – The Pharma New Drug Product Platform We are a world leading purpose-built PSA and PPM solution for all aspects of pharma – we work across pharma generics, CRO and CDMO – with out-of-the-box NPD workflows that align with how drug product development occurs within regulated environments. Kytes is not a general purpose PPM solution re-skinned for Pharma – Kytes is a truly dedicated Pharma New Drug Product development platform.

Pharmaceutical organisations on Kytes report:

